Carvajal, R. D., Nathan, P., Sacco, J. J., Orloff, M., Hernandez-Aya, L. F., Yang, J., Luke, J. J., Butler, M. O., Stanhope, S., Collins, L., McAlpine, C., Holland, C., Abdullah, S. E., & Sato, T. (2022). Phase I Study of Safety, Tolerability, and Efficacy of Tebentafusp Using a Step-Up Dosing Regimen and Expansion in Patients With Metastatic Uveal Melanoma. Journal of Clinical Oncology, 40(17), 1939–1948. https://doi.org/10.1200/jco.21.01805
Subjects:
Immunoconjugates
(MeSH)
Melanoma
(MeSH)
Neoplasms, Second Primary
(MeSH)
Uveal Neoplasms
(MeSH)
Chimeric Antigen Receptor T Cell Therapy
(OpenAlex Topic)
Immunobiology of Dendritic Cells
(OpenAlex Topic)
Ocular Cancer Research and Treatment
(OpenAlex Topic)
Publication Type:
Article
Unique ID:
10.1200/JCO.21.01805
PMID:
DOI:
Journal:
Publication Date:
Data Source:
Scopus